Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Dr. Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Professor | University of Toronto | Canada

Dr. Marla Shapiro is an Associate Professor at the University of Toronto, Canada, specializing in menopause research, vasomotor symptoms, and women’s midlife health. Her scholarship focuses on advancing evidence-based, non-hormonal and hormonal therapeutic strategies for managing moderate to severe menopausal symptoms. She has published 34 peer-reviewed articles, receiving 1,713 citations, with an h-index of 14, demonstrating consistent academic influence. Dr. Shapiro has played a key role in international phase 3 and 3b clinical trials, including responder and pooled analyses of fezolinetant, published in leading journals such as Maturitas and Menopause. Through collaborations with more than 180 international co-authors, her work has informed clinical decision-making, supported guideline development, and contributed meaningfully to improving quality of life and healthcare outcomes for menopausal women worldwide.

Citation Metrics (Scopus)

1713
1200
800
400
0

Citations

1,713

Documents

34

h-index

14

Citations

Documents

h-index

View Scopus Profile
View ResearchGate Profile

Featured Publications

Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Dr. Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Dirigente Responsabile | Azienda Ospedaliera | Italy

Dr. Giuseppina Peluso is a researcher at the AO of Cosenza in Italy, specializing in reproductive biology with an emphasis on the molecular and cellular mechanisms governing human sperm function. Her work explores the balance between pro-survival and pro-apoptotic pathways, offering deeper insight into the biological foundations of male infertility. Through sustained scientific contributions and broad interdisciplinary collaborations, she advances understanding of how molecular signaling influences sperm quality and reproductive potential. Her research supports the development of innovative therapeutic approaches and contributes to improving clinical strategies in andrology and reproductive health. Peluso’s commitment to evidence-based investigation continues to generate meaningful impact within both scientific and healthcare communities.

Citation Metrics (Scopus)

103
75
50
25
0

Citations

103

Documents

12

h-index

6

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Felicia Antohe | Health Professions | Excellence in Research

Dr. Felicia Antohe | Health Professions | Excellence in Research

Head of Proteomics Department at Inst. Cellular Biology and Pathology NS, Romania

Dr. Felicia Antohe, a distinguished researcher and Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, is a highly suitable candidate for the Excellence in Research Award. With a Ph.D. in Cellular Biology and over 170 scientific publications, including 90 indexed in Web of Science and over 2,500 citations, she has made significant contributions to biomedical sciences. Her expertise spans proteomics, vascular biology, monoclonal antibody technology, and molecular mechanisms of macromolecular transport. Dr. Antohe has led over 44 national and international research projects, mentored numerous Ph.D. students, and held key roles in prestigious European scientific committees, including as an expert evaluator for EC Framework Programs. Recognized globally with multiple international awards and fellowships, her work has advanced knowledge in atherosclerosis, immune disorders, and endothelial cell biology. Her strong leadership, innovative research, and dedication to scientific excellence make her an exemplary candidate for this honor.

Professional Profile 

Education🎓

Dr. Felicia Antohe holds a robust academic background in the life sciences, beginning with a Master’s degree in Biophysics from the University of Bucharest, Faculty of Physics, completed between 1972 and 1977. She later pursued her doctoral studies at the Romanian Academy’s Institute of Cellular Biology and Pathology (IBPC N. Simionescu), where she earned a Ph.D. in Cellular Biology between 1985 and 1994. In 2000, she was accredited as a Ph.D. Coordinator in Cellular Biology by the Romanian Academy and the Ministry of Education and Research. Her education has been complemented by extensive international training and research fellowships at prestigious institutions such as McGill University (Canada), University of Alberta (Canada), Max Planck Institute (Germany), and Université René Descartes (France), among others. This rich educational foundation has equipped Dr. Antohe with interdisciplinary expertise spanning biophysics, molecular biology, immunology, and proteomics, laying the groundwork for her prolific and impactful scientific career.

Professional Experience📝

Dr. Felicia Antohe has an extensive and distinguished professional background in biomedical research, currently serving as Head of the Proteomics Department at the Institute of Cellular Biology and Pathology “N. Simionescu” of the Romanian Academy. She has also led the Monoclonal Antibody Laboratory and serves as a Ph.D. Coordinator in Cellular Biology. With over four decades of experience, she has acted as Principal Investigator on more than 44 nationally and internationally funded research projects and has mentored numerous Ph.D. and postgraduate students. Her international experience includes research fellowships and visiting scientist roles at top institutions such as McGill University, University of Alberta, Max Planck Institute, and Université René Descartes. She has served as an expert evaluator for EU Framework Programs (FP6, FP7), contributed to national research councils, and held leadership roles in international scientific networks like COST and the Central and Eastern European Proteomic Conferences. Her work integrates academic leadership with pioneering research.

Research Interest🔎

Dr. Felicia Antohe’s research interests lie at the intersection of cellular biology, molecular biology, and biomedical sciences, with a particular focus on the vascular endothelium. Her work explores the molecular mechanisms of macromolecule transport across endothelial cells, including transcytosis and endocytosis, in both healthy and pathological conditions such as atherosclerosis, diabetes, and immune disorders. She is deeply engaged in the study of membrane microdomains—lipid rafts and caveolae—and their structural and functional roles in cellular signaling and transport. Dr. Antohe is also an expert in proteomics, utilizing mass spectrometry and bioinformatics to analyze endothelial cell proteins in health and disease. Her research extends into the biotechnology of monoclonal and polyclonal antibodies for diagnostic and therapeutic applications. With a strong foundation in immunochemistry, molecular diagnostics, and nanostructured materials, her interdisciplinary investigations contribute to advancing biomedical knowledge and improving clinical strategies for vascular and systemic inflammatory diseases.

Award and Honor🏆

Dr. Felicia Antohe has received numerous prestigious awards and honors in recognition of her outstanding contributions to biomedical research. Internationally, she was awarded the EURESCO Prize for her work on membrane dynamics, and received the BIO-RAD Laboratories Prize for valuable scientific contributions. Her research has been recognized with the IIIrd Award at the International Congress of Medical Sciences in Bulgaria, and the Best Poster Award at the 8th International Conference on Vascular Endothelium in Greece. She has also earned fellowships, including the ESF grant for EURESCO Conferences and a Summer School Fellowship in Scotland. Nationally, she received the esteemed Emil Racoviță Prize from the Romanian Academy and eight other awards from institutions such as the University of Bucharest and CNCSIS. Additionally, she has been an invited speaker at numerous global conferences and authored monographs featured in over 1,900 international libraries, cementing her influence in the scientific community.

Research Skill🔬

Dr. Felicia Antohe possesses an exceptional array of research skills, developed through decades of pioneering work in cellular biology and proteomics. Her technical expertise encompasses a broad range of advanced methodologies, including immunological techniques such as monoclonal antibody production, FACS, ELISA, and immunocytochemistry. She is highly proficient in molecular biology tools, including PCR, RT-qPCR, in situ hybridization, and plasmid transfection. Dr. Antohe is also skilled in cell biology practices like cell culture, fluorescence and electron microscopy, and animal modeling. Her proteomics capabilities include 1D and 2D SDS-PAGE, protein radio-labeling, scintillation and gamma counting, and mass spectrometry, coupled with strong bioinformatics analysis. She has also applied her knowledge to complex systems such as lipid rafts, transcytosis, and membrane receptor function. In addition to hands-on techniques, she excels in mentoring young scientists and PhD students, reflecting her strong leadership in research training and laboratory development.

Conclusion💡

Dr. Felicia Antohe is highly suitable for an Excellence in Research Award, particularly one recognizing:

  • Lifetime achievements

  • Biomedical innovation

  • Mentorship

  • Leadership in research ecosystems

Her academic depth, scientific rigor, and institutional leadership align strongly with the core mission of such an award. While certain modern metrics (e.g., recent societal impact or innovation transfer) could be elaborated more, these are secondary when weighed against the breadth and depth of her contributions.

Publications Top Noted✍️

  • Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., et al. (2001). The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans. International Immunology, 13(8), 993–1002.
    📌 Citations: 404

  • Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., et al. (1998). Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. International Immunology, 10(9), 1289–1298.
    📌 Citations: 308

  • Simionescu M., Gafencu A., Antohe F. (2002). Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microscopy Research and Technique, 57(5), 269–288.
    📌 Citations: 272

  • Antohe F., Rădulescu L., Gafencu A., Gheţie V., Simionescu M. (2001). Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Human Immunology, 62(2), 93–105.
    📌 Citations: 204

  • Van Gool A., Corrales F., Čolović M., Krstić D., Oliver-Martos B., Antohe F., et al. (2020). Analytical techniques for multiplex analysis of protein biomarkers. Expert Review of Proteomics, 17(4), 257–273.
    📌 Citations: 95

  • Simionescu M., Antohe F. (2006). Functional ultrastructure of the vascular endothelium: changes in various pathologies. In: The Vascular Endothelium I, pp. 41–69.
    📌 Citations: 90

  • Manduteanu I., Voinea M., Antohe F., Dragomir E., Capraru M., Radulescu L., et al. (2003). Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology, 477(3), 269–276.
    📌 Citations: 85

  • Lixandru B.E., Cotar A.I., Straut M., Usein C.R., Cristea D., Ciontea S., Antohe F., et al. (2015). Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey. PLoS ONE, 10(11), e0143214.
    📌 Citations: 66

  • Antohe F., Dobrila L., Heltianu C., Simionescu N., Simionescu M. (1993). Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. European Journal of Cell Biology, 60(2), 268–275.
    📌 Citations: 66

  • Haraba R., Suica V.I., Uyy E., Ivan L., Antohe F. (2011). Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein. Cell and Tissue Research, 346, 361–368.
    📌 Citations: 53

Qintai Yang | Medicine and Dentistry | Best Researcher Award

Prof. Qintai Yang | Medicine and Dentistry | Best Researcher Award

Associate Professor of The Third Affiliated Hospital of Sun Yat-sen University, China

Prof. Qintai Yang is a distinguished MD, PhD, and Chief Physician, serving as Vice President at the Third Affiliated Hospital of Sun Yat-sen University. 🏥 His leadership extends across multiple departments, including Otorhinolaryngology-Head and Neck Surgery, Allergy, and the Naso-Orbital-Maxilla and Skull Base Center. 🌟 Prof. Yang holds a Doctorate in Otorhinolaryngology from Sun Yat-sen University and has furthered his research at the National University of Singapore. 🎓 His impactful work includes leading 22 research projects and publishing over 70 articles in top journals like The New England Journal of Medicine and BMJ. 📚 He is also recognized for his contributions with over 10 patents and his role in developing clinical guidelines and popular science articles. 🏆 His innovative research and dedication to medical science have earned him awards such as the Guangdong Province Outstanding Young Medical Talent. 🌟

Professional profile

Education📚

Prof. Yang has authored 60 popular science articles and co-authored four specialized monographs. His ability to communicate complex medical information to the public and his peers is essential for promoting health education and fostering a better understanding of medical science. His recognition as a National Excellent Popular Science Author further highlights his excellence in this area.

Professional Experience🏛️

Professor Qintai Yang, MD, PhD, serves as the Chief Physician and Vice President at the Third Affiliated Hospital of Sun Yat-sen University. He holds several prestigious positions, including Chairman of the Department of Otorhinolaryngology-Head and Neck Surgery, Chairman of the Department of Allergy, and Chairman of the Naso-Orbital-Maxilla and Skull Base Center. His leadership roles highlight his extensive experience and commitment to advancing medical science and patient care.

Research Contributions🌐

Prof. Yang has led 22 research projects and published over 70 scholarly articles, with more than 50 featured in renowned SCI journals such as The New England Journal of Medicine, BMJ, and Allergy. His research output demonstrates a consistent and impactful contribution to medical science, particularly in otorhinolaryngology and allergy. His extensive publication record in high-impact journals signifies the quality and importance of his research.

Awards and Recognitions🏆

Prof. Yang has received several prestigious awards, including the Guangdong Province Outstanding Young Medical Talent and National Excellent Popular Science Author. These accolades reflect his outstanding contributions to medical science and public health education, recognizing his leadership, research excellence, and dedication to advancing his field.

Publications top noted 📜
  1. 📚 Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
    • Authors: Lin, J., Wang, C., Wang, X., … Zhou, X., Zhang, L.
    • Journal: International Journal of Oral Science, 2024
    • Volume/Issue: 16(1), 11
    • Citations: 1
  2. 📘 Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    • Authors: Ye, F., Zhang, H., Luo, X., … Yang, Q., Shi, Z.
    • Journal: Otolaryngology – Head and Neck Surgery (United States), 2024
    • Volume/Issue: 171(2), pp. 571–577
    • Citations: 0
  3. 📖 Educational attainment increases the risk of developing allergic rhinitis and (or) eczema: a Mendelian randomization study based on genome-wide association studies in European patients
    • Authors: Zheng, R., Liu, Z., Chen, Z., … Zhang, J., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2024
    • Volume/Issue: 58(6), pp. 791–798
    • Citations: 0
  4. 📙 Based on CT imaging, surgical approach selection for frontal and ethmoid sinus osteoma
    • Authors: Guo, M., Wu, X., Yuan, T., … Zhang, G., Shi, Z.
    • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2024
    • Volume/Issue: 38(6), pp. 523–529
    • Citations: 0
  5. 📕 Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China: A national multicenter survey of 35,566 individuals
    • Authors: Liu, M.-F., Ma, R.-X., Cao, X.-B., … Cheng, L., Liu, J.-F.
    • Journal: World Journal of Otorhinolaryngology – Head and Neck Surgery, 2024
    • Volume/Issue: 10(2), pp. 113–120
    • Citations: 0
  6. 📔 Application of image-based artificial intelligence in rhinology
    • Authors: Chao, W.H., Luo, X., Liang, G.X., … Shi, Z.H., Yang, Q.T.
    • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2024
    • Volume/Issue: 59(3), pp. 277–283
    • Citations: 0
  7. 📗 Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice
    • Authors: Wang, R., Wang, Y., Yang, Q., … Ruan, Y., Zhou, M.
    • Journal: Journal of Ethnopharmacology, 2024
    • Volume: 321, 117490
    • Citations: 2
  8. 📓 Body mass index’s effect on CRSwNP extends to pathological endotype and recurrence
    • Authors: Chen, W., Bai, Y., Fang, P., … Yang, Q., Zhang, Y.
    • Journal: Rhinology, 2024
    • Volume/Issue: 62(3), pp. 370–382
    • Citations: 0
  9. 📒 Characteristics and therapeutic strategies of Potts puffy tumor
    • Authors: Deng, H., Chen, Z., Wu, X., Yang, Q.
    • Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2024
    • Volume/Issue: 38(1)
    • Citations: 0
  10. 📙 Preliminary insights into the practice of hypoallergenic home visiting program
    • Authors: Zhang, H., Zhou, M., Zhou, Q., … Chen, Z., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2023
    • Volume/Issue: 57(12), pp. 1957–1963
    • Citations: 0

Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Dr. Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Attending Physician of Jiangsu Provincial People’s Hospital, China

Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. 🌟 With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. 🎓 His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. 👨‍🏫👩‍🏫 Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. 🏠👨‍⚕️ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.

Professional profile

Education📚

Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. 🎓 He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. 📜 Prior to this, he completed his Master’s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. 🏅 Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.

Professional Experience🏛️

Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. 💼 His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. 🏥 With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. 🩺 His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. 🌟

Research Interest🌐

Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. 🔬 His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. 🏥💡 Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. 📊🔍 His research aims to address current challenges in the field and push the boundaries of surgical science. 🌟

Awards and Honors🏆

Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. 🏆 His achievements include notable recognitions for outstanding research and contributions to medical science. 🌟 Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. 🏅✨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. 🏥👏

Research skill🔬

Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. 🔬 He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. 📊 With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. 💡 His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. 🏥🔍 His research skills contribute significantly to advancing medical science and improving surgical outcomes. 🌟📈

Achievements🏅
  • 🎓 Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
  • 🏅 Master’s Degree in Surgery from Nanjing Medical University
  • 🩺 Professional Certification in Surgery
  • 👨‍⚕️ Completed Standard Training in clinical practice
  • 🌟 Significant Contributions to surgical techniques and patient care innovations
  • 🔬 Advanced Research in surgical methods and technologies
Projects🛠️
  • 🏥 Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
  • 🔬 Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
  • 📊 Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
  • 💡 Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
  • 🧪 Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
Publication📜
  • RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
    • 📝 Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
    • 📅 Year: 2024
    • 🗞️ Journal: Cancer Letters
    • 📈 Citations: 0
  • Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
    • 📝 Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
    • 📅 Year: 2024
    • 🗞️ Journal: Cellular Signalling
    • 📈 Citations: 0
  • MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
    • 📝 Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Oncogene
    • 📈 Citations: 3
  • Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
    • 📝 Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Cell Metabolism
    • 📈 Citations: 10
  • KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma
    • 📝 Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Oncogene
    • 📈 Citations: 8
  • Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
    • 📝 Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Cancer Gene Therapy
    • 📈 Citations: 13
  • Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
    • 📝 Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: International Journal of Biological Sciences
    • 📈 Citations: 1
  • NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    • 📝 Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: International Journal of Biological Sciences
    • 📈 Citations: 6
  • CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
    • 📝 Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
    • 📅 Year: 2022
    • 🗞️ Journal: Journal of Experimental and Clinical Cancer Research
    • 📈 Citations: 32
  • ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
    • 📝 Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
    • 📅 Year: 2022
    • 🗞️ Journal: Frontiers in Oncology
    • 📈 Citations: 2